AGN News and Press, Allergan plc From 07/03/19

In recent weeks I’ve written several pieces highlighting the importance of holding cash. I’ve mentioned that the market has rallied back to all-time highs and attractive values are difficult to come by. I’ve said that patience is key to value investing. The same thing goes...

It’s a new month, which means I get to work on the newest episode of my favorite article series: my monthly dividend growth portfolio update. The first thing I do when I start to put together these pieces is total up my monthly dividend income and insert the data into my long-term divid...

Early July is typically one of the two times each calendar year that U.S. drugmakers hike prices. Yesterday, on cue, many appeared to do just that . More news on: GlaxoSmithKline plc, Amneal Pharmaceuticals, Inc., ProShares Ultra Nasdaq Biotechnology ETF, Healthcare stocks news, Stocks on...

By Andy Acker, CFA Global Life Sciences Portfolio Manager Andy Acker discusses how large-cap biopharmaceutical companies utilize M&A strategies to fill product pipelines and maintain steady cash flows. Transcript Andy Acker : Earlier this week, AbbVie ([[ABBV]])...

Merger activity went on a tear last week with twelve new deals announced and one pending deal closing. Deal Statistics: New Deals: The acquisition of Caesars Entertainment Corporation (CZR) by Eldorado Resorts (ERI) for $17.3 billion in a cash plus stock deal. Under the terms of...

Insider buying declined marginally last week with insiders purchasing $131.18 million of stock compared to $132.07 million in the week prior. Selling also decreased with insiders selling $1.14 billion of stock last week compared to $1.18 billion in the week prior. Sell/Buy Ratio: The insid...

Introduction AbbVie ( ABBV ) and Gilead ( GILD ) have both experienced declines in their valuations because of expected and actual declines in revenue and profitability. In AbbVie’s case, the issue is the well-known loss of US patent exclusivity coming in 2023 for its anti-inflammator...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you ca...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...

There is plenty of discussion about AbbVie's ( ABBV ) recent proposal to acquire Allergan ( AGN ). The deal appears to be highly polarizing: some love it, some hate it. Which camp you fall into seems to depend on how much of a cynic you are. Those who love the deal see two companies with enorm...